172 related articles for article (PubMed ID: 34918657)
1. A meta-analysis of XRCC1 single nucleotide polymorphism and susceptibility to gynecological malignancies.
Zhang XQ; Li L
Medicine (Baltimore); 2021 Dec; 100(50):e28030. PubMed ID: 34918657
[TBL] [Abstract][Full Text] [Related]
2. New Concept of X-Ray Repair Cross-Complementing Groups 1 Polymorphisms and Gynecologic Cancer Risk.
Du Y; Wang H; Lv B
Gynecol Obstet Invest; 2018; 83(1):15-22. PubMed ID: 28391259
[TBL] [Abstract][Full Text] [Related]
3. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B
PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981
[TBL] [Abstract][Full Text] [Related]
4. Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects.
Zeng X; Zhang Y; Yue T; Zhang T; Wang J; Xue Y; An R
Oncotarget; 2017 Jan; 8(2):2249-2260. PubMed ID: 27903984
[TBL] [Abstract][Full Text] [Related]
5. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.
Li Y; Liu F; Tan SQ; Wang Y; Li SW
PLoS One; 2012; 7(9):e44441. PubMed ID: 22984511
[TBL] [Abstract][Full Text] [Related]
6. XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms in esophageal cancer risk: a meta-analysis.
Li S; Deng Y; You JP; Chen ZP; Peng QL; Huang XM; Lu QH; Huang XL; Zhao JM; Qin X
Dig Dis Sci; 2013 Jul; 58(7):1880-90. PubMed ID: 23543084
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of the association between XRCC1 Arg399Gln and Arg194Trp polymorphisms and risk of cutaneous melanoma.
Jiang H; Xu W; Zhang F; Wei L; Wang Y; Wang Y; Liu C
Melanoma Res; 2016 Jun; 26(3):290-9. PubMed ID: 26967970
[TBL] [Abstract][Full Text] [Related]
8. Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies.
Xiong Y; Zhang Q; Ye J; Pan S; Ge L
PLoS One; 2018; 13(11):e0206853. PubMed ID: 30408066
[TBL] [Abstract][Full Text] [Related]
9. The nonsynonymous single nucleotide polymorphisms of DNA repair gene XRCC1 and susceptibility to the development of cervical carcinoma and high-risk human papillomavirus infection.
Huang J; Ye F; Chen H; Lu W; Xie X
Int J Gynecol Cancer; 2007; 17(3):668-75. PubMed ID: 17504380
[TBL] [Abstract][Full Text] [Related]
10. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC
PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237
[TBL] [Abstract][Full Text] [Related]
11. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
Xie T; Wang ZG; Zhang JL; Liu H
World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of associations between XRCC1 gene polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis.
Zhang MY; Yang XK; Lv TT; Wu J; Xu SZ; Wang JB; Pan HF; Ye DQ
Int J Rheum Dis; 2018 Jan; 21(1):179-185. PubMed ID: 28198159
[TBL] [Abstract][Full Text] [Related]
13. Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis.
Ma WQ; Han XQ; Wang X; Wang Y; Zhu Y; Liu NF
PLoS One; 2016; 11(11):e0166961. PubMed ID: 27870881
[TBL] [Abstract][Full Text] [Related]
14. Association of XRCC1 gene polymorphisms and pancreatic cancer risk in a Chinese population.
Wang LJ; Wang HT; Wang XX
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323136
[TBL] [Abstract][Full Text] [Related]
15. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.
Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D
Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739
[TBL] [Abstract][Full Text] [Related]
16. XRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision.
Zhao DY; Cheng L; Yu J; Shen H
Cancer Biomark; 2014; 14(6):449-56. PubMed ID: 25335737
[TBL] [Abstract][Full Text] [Related]
17. XRCC1 Arg194Trp and Arg280His polymorphisms increase bladder cancer risk in Asian population: evidence from a meta-analysis.
Fang Z; Chen F; Wang X; Yi S; Chen W; Ye G
PLoS One; 2013; 8(5):e64001. PubMed ID: 23704969
[TBL] [Abstract][Full Text] [Related]
18. XRCC1 polymorphisms increase bladder cancer risk in Asians: a meta-analysis.
Zhang F; Wu JH; Zhao W; Liu HT
Tumour Biol; 2013 Oct; 34(5):2659-64. PubMed ID: 23636799
[TBL] [Abstract][Full Text] [Related]
19. Impact of Interaction between Single Nucleotide Polymorphism of XRCC1, XRCC2, XRCC3 with Tumor Suppressor Tp53 Gene Increases Risk of Breast Cancer: A Hospital Based Case-Control Study.
Datkhile KD; Gudur RA; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3065-3075. PubMed ID: 37774058
[TBL] [Abstract][Full Text] [Related]
20. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis.
Qian K; Liu KJ; Xu F; Chen XY; Chen GN; Yi WJ; Zhou EX; Tang ZH
Asian Pac J Cancer Prev; 2012; 13(12):6385-90. PubMed ID: 23464463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]